Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Adjuvant compositions

a technology of adjuvant compositions and compositions, applied in the field of adjuvant compositions, can solve the problems of weak and transient t-cell response, not all of these mechanisms are necessarily activated, and many antigens are poorly immunogenic or non-immunogenic,

Pending Publication Date: 2022-09-08
NANOBIO CORP +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The patent describes a method for generating an immune response in a person by giving them a combination of antigens and an emulsion with immunostimulatory compounds. This can lead to different types of immune responses, such as the initial response when a person comes into contact with a new antigen, as well as long-term memory responses that can protect the person from the same antigen in the future. The method can also involve detectable changes in the immune system, such as increased TLR activation or the production of specific proteins. Overall, the invention provides a way to stimulate the immune system and protect against disease.

Problems solved by technology

However, not all of these mechanisms are necessarily activated after immunization.
Many antigens are poorly immunogenic or non-immunogenic when administered by themselves.
Killed or subunit vaccines are often poorly immunogenic, and can result in weak and transient T-cell responses, thus requiring adjuvants to boost the immune response.
A major impediment in the development of novel vaccines has been the lack of safe yet effective vaccine adjuvants.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Adjuvant compositions
  • Adjuvant compositions
  • Adjuvant compositions

Examples

Experimental program
Comparison scheme
Effect test

example 1

rH5 Antigen, QS-21, CpG and Nanoemulsion

[0195]A series of experiments were generated and conducted in order to identify and characterize the adjuvant properties of various different emulsion delivery systems in combination with different immunostimulatory compounds. In particular, experiments were conducted during development of embodiments of the invention in order to evaluate the combination of 3 different adjuvants, a TLR9 agonist, composed of synthetic oligodeoxynucleotides (ODN) containing immunostimulatory CpG motifs (CpG), a QS-21 and nanoemulsion adjuvant, composed of two surfactants, oil, and organic solvent, which possesses both immunostimulatory and delivery properties. While individual adjuvant members have previously been documented to be effective adjuvants, there exists no report or data in the field indicating what might happen to the adjuvant properties of each individual adjuvant member if the members are combined.

[0196]Accordingly, combinations of various TLR agon...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention provides methods and compositions for the stimulation of immune responses. In particular, the invention provides methods and compositions for enhancing an immune response to one or more antigens. Compositions and methods of the invention are useful for the treatment and / or prevention of microbial infections, such as infections caused by bacteria, viruses, fungi, and parasites, as well as the treatment and / or prevention of cancer and malignant diseases. Compositions and methods of the invention include one or more antigens / immunogens together with an adjuvant formulation comprising an emulsion delivery system in combination with one or more immunostimulatory compounds (e.g., a compound that stimulates the innate immune system (e.g., a toll-like receptor antagonist (e.g., synthetic oligodeoxynucleotides (ODN)))) that enhance immune responses to the one or more antigens / immunogens when administered to a subject. Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic and preventative medicine (e.g., vaccination)) and research applications.

Description

FIELD OF THE INVENTION[0001]The present invention provides methods and compositions for the stimulation of immune responses. In particular, the invention provides methods and compositions for enhancing an immune response to one or more antigens. Compositions and methods of the invention are useful for the treatment and / or prevention of microbial infections, such as infections caused by bacteria, viruses, fungi and parasites. Compositions and methods of the invention include one or more antigens / immunogens together with an adjuvant formulation comprising an emulsion delivery system in combination with one or more immunostimulatory compounds (e.g., a compound that stimulates the innate immune system (e.g., a toll-like receptor antagonist (e.g., synthetic oligodeoxynucleotides (ODN)))) that enhance immune responses to the one or more antigens / immunogens when administered to a subject. Compositions and methods of the invention find use in, among other things, clinical (e.g. therapeutic ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): F01N3/28
CPCF01N3/2892A61K39/12C12N2760/16134A61K2039/55566A61K2039/55577A61K2039/55561A61K39/39A61P37/04A61K9/1075A61K39/385A61K39/295
Inventor BAKER, JR., JAMES R.SMITH, DOUGLAS M.CIOTTI, SUSAN
Owner NANOBIO CORP
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com